Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway

Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway

Background: Ezetimibe is used to treat cardiovascular disease as it blocks the sterol transporter Niemann-Pick C1-Like 1 (NPC1CL1) protein. However, recent evidence indicates that Ezetimibe inhibits several cancers indirectly by reducing circulating cholesterol or via specific signalling pathways. M...

Full description

Saved in:

Bibliographic Details
Main Authors:	Charmy Twala, Sibusiso Malindisa, Chamone Munnik, Selisha Sooklal, Monde Ntwasa
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomedicines
Subjects:	p53 Mdm2 drug design drug development drug repurposing Ezetimibe
Online Access:	https://www.mdpi.com/2227-9059/13/1/195
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway
by: Ming Xu, et al.
Published: (2024-04-01)

Association between ТР53, MDM2 and NQO1 gene polymorphisms and viral load among women with human papillomavirus
by: A.H. AlBosale, et al.
Published: (2022-03-01)

Repurposing the Antidiabetic Drugs Glyburide, Gliquidone, and Glipizide in Combination with Benznidazole for <i>Trypanosoma cruzi</i> Infection
by: Citlali Vázquez, et al.
Published: (2024-12-01)

The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis
by: O. Bulgakova, et al.
Published: (2020-12-01)

HEDDI-Net: heterogeneous network embedding for drug-disease association prediction and drug repurposing, with application to Alzheimer’s disease
by: Yin-Yuan Su, et al.
Published: (2025-02-01)

Comprehensive evaluation of pure and hybrid collaborative filtering in drug repurposing
by: Clémence Réda, et al.
Published: (2025-01-01)

Dual EMCV-IRES-integrated dengue virus can express an exogenous gene and cellular Mdm2 integration suppresses the dengue viral replication
by: Tadahisa Teramoto
Published: (2025-01-01)

Proteome-Wide Identification and Comparison of Drug Pockets for Discovering New Drug Indications and Side Effects
by: Renxin Zhang, et al.
Published: (2025-01-01)

Editorial: New insights into intracellular pathways and therapeutic targets in CNS diseases
by: Lisa Gherardini
Published: (2025-02-01)

Editorial: Latest findings on Leishmania parasites for better vaccine design and drug development
by: Negar Seyed, et al.
Published: (2025-01-01)

Joint embedding–classifier learning for interpretable collaborative filtering
by: Clémence Réda, et al.
Published: (2025-01-01)

Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma
by: Assem Barakat, et al.
Published: (2025-01-01)

Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates
by: Panagiotis N. Lalagkas, et al.
Published: (2024-11-01)

Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures
by: Mariana Nunes, et al.
Published: (2024-12-01)

Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
by: Jarosz-Biej Magdalena, et al.
Published: (2025-02-01)

Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers
by: A.N.K.V. Sravani, et al.
Published: (2025-02-01)

IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials
by: Jihan K. Zaki, et al.
Published: (2025-03-01)

Integrative transcriptome profiling for identifying ALS potential treatment using the drug repurposing approach
by: Navid Kashani, et al.
Published: (2025-01-01)

Advances and Challenges in Antiviral Development for Respiratory Viruses
by: Luis Adrián De Jesús-González, et al.
Published: (2024-12-01)

Improving drug repositioning with negative data labeling using large language models
by: Milan Picard, et al.
Published: (2025-02-01)

Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis
by: Bonnie Hei Man Liu, et al.
Published: (2025-02-01)

DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer’s disease
by: Victor O. K. Li, et al.
Published: (2025-01-01)

Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01)

A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
by: Bohao Zhang, et al.
Published: (2025-01-01)

Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53
by: Lingli Gong, et al.
Published: (2025-01-01)

A novel approach for target deconvolution from phenotype-based screening using knowledge graph
by: Xiaohong Wang, et al.
Published: (2025-01-01)

From the Criminalization of Substances to the “War on Drugs” Policy: A Century of Prohibitionism in Brazil
by: José Guilherme Magalhães e Silva, et al.
Published: (2024-06-01)

Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report
by: Yuki Miyata, et al.
Published: (2025-01-01)

Rutin attenuates zearalenone-induced ferroptosis of endometrial stromal cells in piglets through the p53 signaling pathway
by: Chenlong Wang, et al.
Published: (2025-01-01)

Immunohistochemical evaluation of P53 in squamous cell carcinoma of the esophagus
by: Kala K, et al.
Published: (2024-10-01)

University proceedings. Volga region. Social sciences
by: E.V. Bityutskiy, et al.
Published: (2024-11-01)

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
by: Fatih Ciftci, et al.
Published: (2025-01-01)

BRCA1 is involved in sustaining rapid antler growth possibly via balancing of the p53/endoplasmic reticulum stress signaling pathway
by: Qianqian Guo, et al.
Published: (2025-01-01)

Scalable Manufacturing Method for Model Protein-Loaded PLGA Nanoparticles: Biocompatibility, Trafficking and Release Properties
by: Selin Akpinar Adscheid, et al.
Published: (2025-01-01)

Sitagliptin: a potential drug for the treatment of COVID-19?
by: Bardaweel Sanaa K., et al.
Published: (2021-06-01)

Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
by: Lu Hu, et al.
Published: (2025-01-01)

Investigation into the Effect of Aspartame on the Expression of p53 and BAX in Mouse Stomach Tissue
by: Angelique Cheryl, et al.
Published: (2024-12-01)

Ginger polysaccharide UGP1 suppressed human colon cancer growth via p53, Bax/Bcl-2, caspase-3 pathways and immunomodulation
by: Yanfang Qian, et al.
Published: (2023-03-01)

Deprescribing: An umbrella review
by: Japelj Nuša, et al.
Published: (2024-06-01)

Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities
by: Nai Lee, et al.
Published: (2025-01-01)